Back
Century Aluminum 10K Form
Sell
37
CENX
Century Aluminum
Last Price:
16.27
Seasonality Move:
-0.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | CENX/Century Aluminum Quarterly |
2023-08-09 | 10Q | CENX/Century Aluminum Quarterly |
2023-05-09 | 10Q | CENX/Century Aluminum Quarterly |
2022-11-07 | 10Q | CENX/Century Aluminum Quarterly |
2022-08-09 | 10Q | CENX/Century Aluminum Quarterly |
2022-05-02 | 10Q | CENX/Century Aluminum Quarterly |
Receive CENX News And Ratings
See the #1 stock for the next 7 days that we like better than CENX
CENX Financial Statistics
Sales & Book Value
Annual Sales: | $2.19B |
---|---|
Cash Flow: | $-44.5M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.49 |
Price / Book: | 2.51 |
Profitability
EPS (TTM): | 2.18000 |
---|---|
Net Income (TTM): | $242.3M |
Gross Margin: | $91.9M |
Return on Equity: | 58.1% |
Return on Assets: | 14.08% |
Century Aluminum Earnings Forecast
Key Century Aluminum Financial Ratios
- The Gross Profit Margin over the past 28 years for CENX is 4.21%.
- The Selling, General & Administrative Expenses for CENX have been equal to 2.03% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -82.37% of Operating Income.
- The Net Earning history of CENX is -1.97% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 10 years.
Century Aluminum Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | CENX |
CUSIP: | 156431 |
Website: | centuryaluminum.com |
Debt
Debt-to-Equity Ratio: | 0.88 |
---|---|
Current Ratio: | 1.67 |
Quick Ratio: | 0.56 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 16.9 |
CENX Technical Analysis vs Fundamental Analysis
Sell
37
Century Aluminum (CENX)
is a Sell
Is Century Aluminum a Buy or a Sell?
-
Century Aluminum stock is rated a Sell
The current Century Aluminum [CENX] share price is $16.28. The Score for CENX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.